Comparative preclinical biodistribution, dosimetry and endoradiotherapy in mCRPC of 177Lu-rhPSMA-7.3 and 177Lu-PSMA I&T

被引：0
|
作者：
Yusufi, N. [1 ]
Nekolla, S. [1 ]
Wurzer, A. [2 ]
Herz, M. [1 ]
D'Alessandria, C. [1 ]
Weber, W. [1 ]
Wester, H. J. [2 ]
Eiber, M. [1 ]
机构：
[1] Tech Univ Munich, Dept Nucl Med, Klinikum Rechts Isar, Munich, Germany
[2] Tech Univ Munich, Chair Pharmaceut Radiopharm, Garching, Germany
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2020年 / 47卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP-274
引用
收藏
页码：S642 / S643
页数：2
相关论文
共 50 条
  • [1] Comparative Preclinical Biodistribution, Dosimetry, and Endoradiotherapy in Metastatic Castration-Resistant Prostate Cancer Using 19F/177Lu-rhPSMA-7.3 and 177Lu-PSMA I&T
    Yusufi, Nahid
    Wurzer, Alexander
    Herz, Michael
    D'Alessandria, Calogero
    Feuerecker, Benedikt
    Weber, Wolfgang
    Wester, Hans-Juergen
    Nekolla, Stephan
    Eiber, Matthias
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62 (08) : 1106 - 1111
  • [2] Pretherapeutic Comparative Dosimetry of 177Lu-rhPSMA-7.3 and 177Lu-PSMA I&T in Patients with Metastatic Castration-Resistant Prostate Cancer
    Feuerecker, Benedikt
    Chantadisai, Maythinee
    Allmann, Anne
    Tauber, Robert
    Allmann, Jakob
    Steinhelfer, Lisa
    Rauscher, Isabel
    Wurzer, Alexander
    Wester, Hans-Juergen
    Weber, Wolfgang A.
    d'Alessandria, Calogero
    Eiber, Matthias
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63 (06) : 833 - 839
  • [3] Preclinical comparison of [177Lu]Lu-rhPSMA-10.1 and [177Lu]Lu-rhPSMA-10.2 for endoradiotherapy of prostate cancer: biodistribution and dosimetry studies
    Wurzer, Alexander
    De Rose, Francesco
    Fischer, Sebastian
    Schwaiger, Markus
    Weber, Wolfgang
    Nekolla, Stephan
    Wester, Hans-Juergen
    Eiber, Matthias
    D'Alessandria, Calogero
    EJNMMI RADIOPHARMACY AND CHEMISTRY, 2024, 9 (01)
  • [4] Preclinical comparison of [177Lu]Lu-rhPSMA-10.1 and [177Lu]Lu-rhPSMA-10.2 for endoradiotherapy of prostate cancer: biodistribution and dosimetry studies
    Alexander Wurzer
    Francesco De Rose
    Sebastian Fischer
    Markus Schwaiger
    Wolfgang Weber
    Stephan Nekolla
    Hans-Jürgen Wester
    Matthias Eiber
    Calogero D’Alessandria
    EJNMMI Radiopharmacy and Chemistry, 9
  • [5] Dosimetry of 177Lu-PSMA
    Serrano, B.
    Amblard, R.
    Koulibaly, P. M.
    Gasteuil, J.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2023, 47 (06): : 323 - 332
  • [6] Improved therapeutic index with the novel PSMA-ligand 177Lu-rhPSMA-10.1 compared to 177Lu-PSMA I&T - an intrapatient comparison
    Rinscheid, Andreas
    Dierks, Alexander
    Kircher, Malte
    Pfob, Christian
    Wengenmair, Hermann
    Wienand, Georgine
    Lapa, Constantin
    Janzen, Tilman
    Bundschuh, Ralph
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [7] Radiochemical Stability of therapeutic radiopharmaceutical of 177Lu-PSMA I&T
    Chandrashekar, R.
    Fagan, J.
    Lim, R.
    Vyas, M.
    INTERNAL MEDICINE JOURNAL, 2022, 52 : 41 - 41
  • [8] Patient dosimetry of 177Lu-PSMA I&T in metastatic prostate cancer treatment: the experience in Thailand
    Kotchakorn Chatachot
    Shuichi Shiratori
    Tawatchai Chaiwatanarat
    Kitiwat Khamwan
    Annals of Nuclear Medicine, 2021, 35 : 1193 - 1202
  • [9] Patient dosimetry of 177Lu-PSMA I&T in metastatic prostate cancer treatment: the experience in Thailand
    Chatachot, Kotchakorn
    Shiratori, Shuichi
    Chaiwatanarat, Tawatchai
    Khamwan, Kitiwat
    ANNALS OF NUCLEAR MEDICINE, 2021, 35 (11) : 1193 - 1202
  • [10] Radiation dosimetric and biodistribution comparison of the PSMA agonists 177Lu-PSMA I&T, 99mTc-Hynic PSMA and 99Tc-PSMA I&T to the 177Lu-RM2 antagonist
    Limouris, G.
    Paphiti, M.
    Zafeirakis, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S459 - S459
12345